Dr Julie Gerberding was named FNIH’s CEO to rebuild their approach to amplify the patient’s voice across all of the FNIH’s programs to provide greater impact on both science and patient outcomes.
Lead Webcast

Dr Julie Gerberding was named FNIH’s CEO to rebuild their approach to amplify the patient’s voice across all of the FNIH’s programs to provide greater impact on both science and patient outcomes.